Literature DB >> 9045664

The majority of stem cell factor exists as monomer under physiological conditions. Implications for dimerization mediating biological activity.

Y R Hsu1, G M Wu, E A Mendiaz, R Syed, J Wypych, R Toso, M B Mann, T C Boone, L O Narhi, H S Lu, K E Langley.   

Abstract

Soluble Escherichia coli-derived recombinant human stem cell factor (rhSCF) forms a non-covalently associated dimer. We have determined a dimer association constant (Ka) of 2-4 x 10(8) M-1, using sedimentation equilibrium and size exclusion chromatography. SCF has been shown previously to be present at concentrations of approximately 3.3 ng/ml in human serum. Based on the dimerization Ka, greater than 90% of the circulating SCF would be in the monomeric form. When 125I-rhSCF was added to human serum and the serum analyzed by size exclusion chromatography, 72-49% of rhSCF was monomer when the total SCF concentration was in the range of 10-100 ng/ml, consistent with the Ka determination. Three SCF variants, SCF(F63C), SCF (V49L,F63L), and SCF(A165C), were recombinantly expressed in Escherichia coli, purified, and characterized. The dimer Ka values, biophysical properties, and biological activities of these variants were studied. Dimerization-defective variants SCF(F63C)S-CH2CONH2 and SCF(V49L,F63L) showed substantially reduced mitogenic activity, while the activity of the Cys165-Cys165 disulfide-linked SCF(A165C) dimer was 10-fold higher than that of wild type rhSCF. The results suggest a correlation between dimerization affinity and biological activity, consistent with a model in which SCF dimerization mediates dimerization of its receptor, Kit, and subsequent signal transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045664     DOI: 10.1074/jbc.272.10.6406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

2.  Design of recombinant stem cell factor-macrophage colony stimulating factor fusion proteins and their biological activity in vitro.

Authors:  Tao Chen; Jie Yang; Yuelang Wang; Chenyang Zhan; Yuhui Zang; Junchuan Qin
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.

Authors:  Chia Chi M Ho; Akanksha Chhabra; Philipp Starkl; Peter-John Schnorr; Stephan Wilmes; Ignacio Moraga; Hye-Sook Kwon; Nicolas Gaudenzio; Riccardo Sibilano; Tom S Wehrman; Milica Gakovic; Jonathan T Sockolosky; Matthew R Tiffany; Aaron M Ring; Jacob Piehler; Irving L Weissman; Stephen J Galli; Judith A Shizuru; K Christopher Garcia
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 4.  No irradiation required: The future of humanized immune system modeling in murine hosts.

Authors:  Brian E McIntosh; Matthew E Brown
Journal:  Chimerism       Date:  2016-05-12

5.  Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation.

Authors:  Z Zhang; R Zhang; A Joachimiak; J Schlessinger; X P Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 6.  Signaling pathways influencing SLF and c-kit-mediated survival and proliferation.

Authors:  Stuart A Berger
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.

Authors:  S Rajaraman; W S Davis; A Mahakali-Zama; H K Evans; L B Russell; M A Bedell
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

Review 8.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

9.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

10.  Characterization of c-Kit expression and activation in KSHV-infected endothelial cells.

Authors:  Janet L Douglas; Jill G Whitford; Ashlee V Moses
Journal:  Virology       Date:  2009-06-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.